Alihankinta - mässa i Finland 2021

Vi hälsar er varmt välkomna att besöka vår monter på Alihankinta Underleverantöremässa i Tammerfors, Finland 21-23 september 2021.


I år ställer vi ut i E-hallen. Träffa vår personal och se tekniska lösningar och produkter för olika industrisegment som Stål & Metall, Papper & Massa, Skog & Såg och Gruvindustrin.


VI SES DÄR! Vår monterplats är E201.



ENTRE 2021.


På grund av Corona-restriktioner gäller din registrering EN specifik dag. Välj nedan. Mer information finns på mässans hemsida. Som vanligt har du fri entré till mässan om du förregistrerar dig här.







Letter from the fair:


Health security takes priority at trade fairs Subcontracting Fair and AlihankintaHEAT are being prepared at this very moment and we are doing everything we can to organize a safe trade fair experience for our clients and staff. We have been having conversations with the authorities (the COVID-19 task force of Pirkanmaa, regional state administrative agency for Western and Inland Finland, and the police) to ensure the conformity of safety plans for our September events and the compliance with all restrictions in force. All of these authorities have shown a green light for our upcoming trade fairs and deemed our preparations relevant for the purpose.


The daily visitor limit is 6000 visitors, which means that during the three fair days the maximum visitor amount is 18 000 visitors. At the recommendation of the regional COVID-19 task force, masks were made mandatory for the fairs. There will also be staff who remind people about the safety distances and we will emphasise the importance of good hygiene. Close contact is defined as a stay of over 15 minutes at a distance less than two metres from other people. The safety distance mandated by AVIs does not concern workplaces or working, which means that the two-metre distance between employees is not necessary. We are also counting on our customers to be responsible and only attend events when healthy, vaccinated, tested, or have already had COVID-19.